Junji Ikeda

3PUBLICATIONS
2CO-AUTHORS
Haematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 14, 2025
PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and monosomy 7.

Hiroyoshi Kunimoto, Ayaka Miura, Maiko Sagisaka

|Feb 01, 2025
Establishment of a high-risk pediatric AML-derived cell line YCU-AML2 with genetic and metabolic vulnerabilities.

Junji Ikeda, Norio Shiba, Shota Kato

|Mar 15, 2019
Whole transcriptome sequencing reveals a KMT2A-USP2 fusion in infant acute myeloid leukemia.

Junji Ikeda, Norio Shiba, Shin-Ichi Tsujimoto

Pageof 1